Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
The Journal of Biological Chemistry
|
June 10, 2015
Topoisomerase II from Human Malaria Parasites: EXPRESSION, PURIFICATION, AND SELECTIVE INHIBITION
Devaraja G Mudeppa, Shiva Kumar, Sreekanth Kokkonda, et al.
Antimicrobial Agents and Chemotherapy
|
June 21, 2021
Properties of Plasmodium falciparum with a Deleted Apicoplast DNA Gyrase
SooNee Tan, Devaraja G Mudeppa, Sreekanth Kokkonda, et al.
Antimicrobial Agents and Chemotherapy
|
January 9, 2024
Tartrolon E, a secondary metabolite of a marine symbiotic bacterium, is a potent inhibitor of asexual and sexual <i>Plasmodium falciparum</i>
Laura Chery-Karschney, Rapatbhorn Patrapuvich, Devaraja Gouda Mudeppa, et al.
Journal of Medicinal Chemistry
|
August 11, 2012
Bioisosteric transformations and permutations in the triazolopyrimidine scaffold to identify the minimum pharmacophore required for inhibitory activity against Plasmodium falciparum dihydroorotate dehydrogenase
Alka Marwaha, John White, Farah El Mazouni, et al.
Journal of Medicinal Chemistry
|
May 8, 2014
Fluorine modulates species selectivity in the triazolopyrimidine class of Plasmodium falciparum dihydroorotate dehydrogenase inhibitors
Xiaoyi Deng, Sreekanth Kokkonda, Farah El Mazouni, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 13, 2022
Repurposed dihydroorotate dehydrogenase inhibitors with efficacy against drug-resistant <i>Acinetobacter baumannii</i>
Thomas A Russo, Timothy C Umland, Xiaoyi Deng, et al.
ACS Omega
|
September 11, 2018
Isoxazolopyrimidine-Based Inhibitors of
Sreekanth Kokkonda, Farah El Mazouni, Karen L White, et al.
Journal of Medicinal Chemistry
|
June 24, 2011
Structure-guided lead optimization of triazolopyrimidine-ring substituents identifies potent Plasmodium falciparum dihydroorotate dehydrogenase inhibitors with clinical candidate potential
Jose M Coteron, María Marco, Jorge Esquivias, et al.
Journal of Medicinal Chemistry
|
April 30, 2016
Tetrahydro-2-naphthyl and 2-Indanyl Triazolopyrimidines Targeting Plasmodium falciparum Dihydroorotate Dehydrogenase Display Potent and Selective Antimalarial Activity
Sreekanth Kokkonda, Xiaoyi Deng, Karen L White, et al.
Journal of Medicinal Chemistry
|
April 7, 2020
Lead Optimization of a Pyrrole-Based Dihydroorotate Dehydrogenase Inhibitor Series for the Treatment of Malaria
Sreekanth Kokkonda, Xiaoyi Deng, Karen L White, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
The Journal of Biological Chemistry
|
June 10, 2015
Topoisomerase II from Human Malaria Parasites: EXPRESSION, PURIFICATION, AND SELECTIVE INHIBITION
Devaraja G Mudeppa, Shiva Kumar, Sreekanth Kokkonda, et al.
Antimicrobial Agents and Chemotherapy
|
June 21, 2021
Properties of Plasmodium falciparum with a Deleted Apicoplast DNA Gyrase
SooNee Tan, Devaraja G Mudeppa, Sreekanth Kokkonda, et al.
Antimicrobial Agents and Chemotherapy
|
January 9, 2024
Tartrolon E, a secondary metabolite of a marine symbiotic bacterium, is a potent inhibitor of asexual and sexual <i>Plasmodium falciparum</i>
Laura Chery-Karschney, Rapatbhorn Patrapuvich, Devaraja Gouda Mudeppa, et al.
Journal of Medicinal Chemistry
|
August 11, 2012
Bioisosteric transformations and permutations in the triazolopyrimidine scaffold to identify the minimum pharmacophore required for inhibitory activity against Plasmodium falciparum dihydroorotate dehydrogenase
Alka Marwaha, John White, Farah El Mazouni, et al.
Journal of Medicinal Chemistry
|
May 8, 2014
Fluorine modulates species selectivity in the triazolopyrimidine class of Plasmodium falciparum dihydroorotate dehydrogenase inhibitors
Xiaoyi Deng, Sreekanth Kokkonda, Farah El Mazouni, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 13, 2022
Repurposed dihydroorotate dehydrogenase inhibitors with efficacy against drug-resistant <i>Acinetobacter baumannii</i>
Thomas A Russo, Timothy C Umland, Xiaoyi Deng, et al.
ACS Omega
|
September 11, 2018
Isoxazolopyrimidine-Based Inhibitors of
Sreekanth Kokkonda, Farah El Mazouni, Karen L White, et al.
Journal of Medicinal Chemistry
|
June 24, 2011
Structure-guided lead optimization of triazolopyrimidine-ring substituents identifies potent Plasmodium falciparum dihydroorotate dehydrogenase inhibitors with clinical candidate potential
Jose M Coteron, María Marco, Jorge Esquivias, et al.
Journal of Medicinal Chemistry
|
April 30, 2016
Tetrahydro-2-naphthyl and 2-Indanyl Triazolopyrimidines Targeting Plasmodium falciparum Dihydroorotate Dehydrogenase Display Potent and Selective Antimalarial Activity
Sreekanth Kokkonda, Xiaoyi Deng, Karen L White, et al.
Journal of Medicinal Chemistry
|
April 7, 2020
Lead Optimization of a Pyrrole-Based Dihydroorotate Dehydrogenase Inhibitor Series for the Treatment of Malaria
Sreekanth Kokkonda, Xiaoyi Deng, Karen L White, et al.
Page
of 2